AAH Pharmaceuticals

AAH.co.uk

The UK's leading wholesaler and distributor of pharmaceutical and healthcare products and services to pharmacy, hospitals and doctors. Supplying a full range of healthcare products including ethicals, generics, PIs and OTCs.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PHARMACY MARKET

THE MCQUADE CENTER FOR STRATEGIC RESEARCH AND DEVELOPMENT AND MINDSET PHARMA COLLABORATE TO DEVELOP PSYCHEDELIC MEDICINES

McQuade | January 06, 2022

news image

The McQuade Center for Strategic Research and Development, LLC, a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurol...

Read More

AMARIN ANNOUNCES PLANS TO MAXIMIZE BLOCKBUSTER POTENTIAL OF VASCEPA® IN EUROPE

Amarin spurns | August 05, 2020

news image

Amarin's wild 2020 ride continues. Tuesday, the company said COVID-19 took a bite out of second quarter earnings, and it unveiled plans to launch its fish-oil derivative drug Vascepa in Europe without help from a bigger marketing partner. And that's on top of prepping for federal court this fall, where it will try to salvage Vascepa's key patents. Amarin positioned its European plans as a positive: It did receive multiple proposals from potential partners. But the significant sales o...

Read More

PHARMA TECH

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

news image

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More

CORONAVIRUS TRACKER: GILEAD'S REMDESIVIR; WHITE HOUSE'S VACCINE PROJECT; PFIZER, BIONTECH'S VACCINE PROGRESS; ASTRAZENECA'S PIPELINE

Fiercepharma | April 29, 2020

news image

As headlines multiplied and analysts began sussing out Gilead Sciences' first controlled trial readout on remdesivir, NIAID director Anthony Fauci hailed the drug as real progress against the virus. Meanwhile, word emerged that the Trump administration is working up a Manhattan Project style vaccine initiative, bringing biotech, pharma and federal agencies together to speed up the work—and let the U.S. government take on the financial risks. Plus, Pfizer and BioNTech said they've d...

Read More
news image

PHARMACY MARKET

THE MCQUADE CENTER FOR STRATEGIC RESEARCH AND DEVELOPMENT AND MINDSET PHARMA COLLABORATE TO DEVELOP PSYCHEDELIC MEDICINES

McQuade | January 06, 2022

The McQuade Center for Strategic Research and Development, LLC, a member of the global Otsuka family of pharmaceutical companies, and Mindset Pharma Inc. announce a collaboration that will support the development of psychedelic medicines. MSRD has made a strategic investment to support the discovery and development of novel chemical entity assets of Mindset, a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic medicines to treat neurol...

Read More
news image

AMARIN ANNOUNCES PLANS TO MAXIMIZE BLOCKBUSTER POTENTIAL OF VASCEPA® IN EUROPE

Amarin spurns | August 05, 2020

Amarin's wild 2020 ride continues. Tuesday, the company said COVID-19 took a bite out of second quarter earnings, and it unveiled plans to launch its fish-oil derivative drug Vascepa in Europe without help from a bigger marketing partner. And that's on top of prepping for federal court this fall, where it will try to salvage Vascepa's key patents. Amarin positioned its European plans as a positive: It did receive multiple proposals from potential partners. But the significant sales o...

Read More
news image

PHARMA TECH

KSP SPECIALTY PHARMACY NOW OFFERS ACCESS TO NON-ONCOLOGY DRUGS AND LAUNCHES NEW WEBSITE FEATURING PHARMACY PATIENT PORTAL

Karmanos Cancer Institute | October 05, 2021

The Barbara Ann Karmanos Cancer Institute and KSP Specialty Pharmacy (KSP) are pleased to announce the launch of new services and a new website: www.ksppharmacy.org. The new site features provider resources and information for payers and pharmaceutical companies. Most notably, the site includes an online portal where patients can refill their prescriptions. This tool also allows patients to see their list of medications, get reminders and interact with their pharmacist. A portal for patient educ...

Read More
news image

CORONAVIRUS TRACKER: GILEAD'S REMDESIVIR; WHITE HOUSE'S VACCINE PROJECT; PFIZER, BIONTECH'S VACCINE PROGRESS; ASTRAZENECA'S PIPELINE

Fiercepharma | April 29, 2020

As headlines multiplied and analysts began sussing out Gilead Sciences' first controlled trial readout on remdesivir, NIAID director Anthony Fauci hailed the drug as real progress against the virus. Meanwhile, word emerged that the Trump administration is working up a Manhattan Project style vaccine initiative, bringing biotech, pharma and federal agencies together to speed up the work—and let the U.S. government take on the financial risks. Plus, Pfizer and BioNTech said they've d...

Read More